Posttranslational modifications of CK‐BB are implicated in aging and other neurological disorders such as Alzheimer's disease, multiple sclerosis or Huntington's disease 11, 12, 14, 56, 57. This evidence concerns the gene CKB and early-onset autosomal dominant Alzheimer disease.